These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34981294)

  • 1. When to start tacrolimus ointment for vernal keratoconjunctivitis? A proposed treatment protocol.
    Arnon R; Rozen-Knisbacher I; Yahalomi T; Stanescu N; Niazov Y; Goldberg D; Sharabi-Nov A; Mostovoy D
    Int Ophthalmol; 2022 Jun; 42(6):1771-1780. PubMed ID: 34981294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.
    Malhotra C; Singh H; Jain AK; Gupta A; Ram J
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1083-1091. PubMed ID: 33764241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis.
    Al-Amri AM; Mirza AG; Al-Hakami AM
    Middle East Afr J Ophthalmol; 2016; 23(1):135-8. PubMed ID: 26957853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
    Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
    Chatterjee S; Agrawal D
    Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population.
    Samyukta SK; Pawar N; Ravindran M; Allapitchai F; Rengappa R
    J AAPOS; 2019 Feb; 23(1):36.e1-36.e5. PubMed ID: 30664932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis.
    Ryu EH; Kim JM; Laddha PM; Chung ES; Chung TY
    Korean J Ophthalmol; 2012 Aug; 26(4):241-7. PubMed ID: 22870021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis.
    Heikal MA; Soliman TT; Abousaif WS; Shebl AA
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):353-361. PubMed ID: 34453603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis.
    Al-Amri AM
    Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
    Wan Q; Tang J; Han Y; Wang D; Ye H
    Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial.
    Eltagoury M; Abou Samra W; Ghoneim E
    Med Hypothesis Discov Innov Ophthalmol; 2022; 11(2):52-63. PubMed ID: 37641784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases.
    Miyazaki D; Tominaga T; Kakimaru-Hasegawa A; Nagata Y; Hasegawa J; Inoue Y
    Ophthalmology; 2008 Jun; 115(6):988-992.e5. PubMed ID: 17900694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
    Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
    Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Clinical Efficacy and Safety of Prolonged Treatment of Vernal and Atopic Keratoconjunctivitis Using Topical Tacrolimus.
    Hirota A; Shoji J; Inada N; Shiraki Y; Yamagami S
    Cornea; 2022 Jan; 41(1):23-30. PubMed ID: 34870621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis.
    Tzu JH; Utine CA; Stern ME; Akpek EK
    Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children.
    Liendo VL; Vola ME; Barreiro TP; Wakamatsu TH; Gomes JÁP; Santos MSD
    Arq Bras Oftalmol; 2017; 80(4):211-214. PubMed ID: 28954018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders.
    Joseph MA; Kaufman HE; Insler M
    Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of topical tacrolimus ointment: a safe and effective option for the treatment of vernal keratoconjunctivitis.
    Müller GG; José NK; de Castro RS; de Holanda EC
    Arq Bras Oftalmol; 2019; 82(2):119-123. PubMed ID: 30698232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of ocular cytology in vernal keratoconjunctivitis.
    Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
    Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.